Pulmonary abscess

General Information

Περιγραφή – Ορισμός

 

Το πνευμονικό απόστημα αποτελεί μία σαφώς περιγεγραμμένη, ενδοπνευμονική, κυκλική βλάβη, που εμπεριέχει πύο, το οποίο αποτελεί το προϊόν της νέκρωσης του πνευμονικού παρεγχύματος εξαιτίας μικροβιακής λοίμωξης (πνευμονίας).

 

Relevant disease coding (ICD10)

 

Types - Forms

Το πνευμονικό απόστημα μπορεί να κατηγοριοποιηθεί ως πρωτοπαθές και δευτεροπαθές:

  • Πρωτοπαθές πνευμονικό απόστημα
    • Παρουσιάζεται συνήθως σε υγιείς ασθενείς μετά από εισρόφηση και αποτελεί το 80% των περιπτώσεων
  • Δευτεροπαθές πνευμονικό απόστημα
    • Παρουσιάζεται συνήθως σε πάσχοντες ασθενείς από νοσήματα όπως:
      • κακοήθεις νεοπλασίες
      • ανοσοκαταστολή (π.χ. HIV)
      • μετεγχειρητικές επιπλοκές

 

Epidemiology

Impact - Prevalence

Δεν αναφέρονται σύγχρονα στοιχεία αναφορικά με την επίπτωση και τον επιπολασμό της νόσου. Αναφέρονται όμως τα πιο συχνά χαρακτηριστικά που παρατηρούνται σε ασθενείς με πνευμονικό απόστημα:

  • προχωρημένη ηλικία
  • ουλίτιδα
  • κατάχρηση αλκοόλ
  • παράγοντες κινδύνου για την αναρρόφηση

 

Παράγοντες Κινδύνου

Οι αναφερόμενοι παράγοντες κινδύνου είναι παρόμοιοι με αυτούς της πρόκλησης πνευμονίας από εισρόφηση και συμπεριλαμβάνουν:

  • μειωμένη συνείδηση, όπως παρατηρείται σε:
    • κατάχρηση αλκοολούχων ή ναρκωτικών
    • αναισθησία και καταστολή
    • νευρολογική δυσλειτουργία
  • περιοδοντική νόσος
  • διαταραχές κινητικότητας οισοφάγου
  • γαστροοισοφαγική παλινδρόμηση
  • δυσφαγία
  • έμετος
  • γαστρική υπερδιάταση
  • καθετήρες σίτισης μεγάλου αυλού
  • ανακλινόμενη θέση
  • έμφραγμα μυοκαρδίου
  • απόφραξη τραχειοβρογχικού δέντρου από νεοπλάσματα ή ξένα σώματα
  • βρογχιεκτασίες

Η εισρόφηση αναερόβιων μικροβίων είναι πιο πιθανό να οδηγήσει σε ιστική νέκρωση και επακόλουθο σχηματισμό αποστήματος σε σύγκριση με την εισρόφηση αερόβιων μικροβίων.

 

Related situations

 

Reason - Pathogenesis

Reason

Οι κυριότεροι αιτιολογικοί παράγοντες δημιουργίας πνευμονικού αποστήματος είναι οι εξής:

  • πολυμικροβιακές λοιμώξεις που σχετίζονται με εισρόφηση:
    • συνήθως από αναερόβια μικρόβια
      • αναφέρονται στο 85-93% των περιπτώσεων
      • η είσοδος των μικροβίων προκαλείται συνήθως από διάσπαση του βλεννογόνου σε έδαφος ουλίτιδας
      • συνήθως απομονώνονται οι εξής μικροοργανισμοί:
        • Peptostreptococcus
        • Prevotella
        • Bacteroides
        • Fusobacterium
  • λοιμώξεις από αερόβια μικρόβια (συνήθως μονομικροβιακές):
    • Streptococcus milleri (μπορεί να συμμετέχει και σε πολυμικροβιακή λοίμωξη)
    • group A Streptococcus
    • Staphylococcus aureus, συμπεριλαμβανομένου του μεθικιλλίνη ανθεκτικού στελέχους
    • S. aureus (MRSA)
    • Klebsiella pneumoniae
    • Escherichia coli
    • Pseudomonas aeruginosa
    • Mycobacteria, συμπεριλαμβανομένου του Mycobacterium tuberculosis
    • Nocardia, κυρίως σε ανοσοκατασταλμένους ασθενείς
    • Rhodococcus
  • λιγότερο συνήθη αίτια:
    • παράσιτα
      • Entamoeba histolytica
      • Paragonimus westermani
    • μύκητες
      • Aspergillus
      • Blastomyces
      • Histoplasma
      • Cryptococcus
      • Zygomycosis

 

Pathogenesis

The most common way is a complication of pneumonia by aspiration:

  • inoculation of microbes in the lung parenchyma by aspiration of large amounts of oral cavity fluids
  • tissue necrosis occurs after 7-14 days and leads to the formation of the abscess
  • in case the abscess communicates with the bronchial tree, purulent and smelly sputum is produced

Other ways of creating the lung abscess are:

  • pulmonary embolism from septic emboli of the right heart chambers in the setting of infective endocarditis
    • usually multiple abscesses are formed
    • abscesses are formed in different (discontinuous) parts of the lung parenchyma
  • haematogenous dissemination from purulent thrombophlebitis (e.g. Lemierre's syndrome)

 

Patient's personal history and clinical examination

 

Clinical picture

The clinical picture of pulmonary abscess due to anaerobic microbes includes the onset of subclinical symptoms, which may last for weeks, such as:

  • cough, fever, purulent expectoration
  • smelly sputum (indicating infection by anaerobic microbes) in 50% of cases
  • in clinically confirmed pulmonary abscess from anaerobic microbes have been observed
    • average temperature 38.9oC
    • average white blood cell count in peripheral blood 15000/mm3
    • average duration of symptoms to diagnosis about 14 days
    • weight loss in 43% of cases

The clinical picture may be lightning-like in cases of Staphylococcus aureus or Klebsiella pneumoniae infection with symptoms such as:

  • high fever
  • leukocytosis
  • early extension of the abscess to other lobes or to the pleural cavity

 

Individual background

 

Main symptom

  • cough, fever, purulent expectoration
  • additional symptoms:
    • chest pain
    • haemoptysis
    • weight loss

 

History of present disease

Symptoms may be subacute or sluggish for weeks, and there may be a history of loss of consciousness or mental disorder.

 

Clinical examination

During the clinical examination, the following are found:

  • fever
  • poor oral hygiene and gingivitis
  • cavernous or sandy breathing whispering
  • absence of pharyngeal reflex
  • keypad finger

 

Diagnosis

 

Diagnostic approach

The diagnosis of pulmonary abscess is typically achieved by performing a chest X-ray in patients with the above-mentioned clinical features:

  • the chest X-ray shows a cavity with a hydraulic plane:
    • usually with a thick wall
    • there may be pulmonary infiltrates surrounding the cavity
  • clinical findings supporting the diagnosis of aspiration lung abscess
    • subclinical symptoms
    • smelly sputum
    • risk factors for causing aspiration
  • clinical picture with a lightning strike usually associated with a monomicrobial infection by Staphylococcus aureus or Klebsiella pneumoniae

Microbiological diagnosis requires isolation of the pathogenic microorganism from sputum or other material of the bronchial tree and has:

  • little benefit-usefulness in isolating anaerobic micro-organisms that are usually contaminated by the normal flora of the oral cavity and respiratory tract
  • high utility-usability in identifying pathogenic micro-organisms causing monomicrobial infections

 

Differential diagnosis

 

The differential diagnosis includes the following conditions:

  • Inspiration
  • septic pulmonary embolism from infectious right ventricular endocarditis
  • neoplasms, including:
    • lung cancer
    • non-Hodgkin's lymphoma
    • metastatic carcinoma
  • pulmonary embolism
    • necrotic pneumonia
      • tuberculosis
      • knockout
      • actinomycosis
      • Rhodococcus
      • Mycosis
        • invasive aspergillosis
        • blastomycosis
        • histoplasmosis
        • coccidiomyelitis
        • cryptococcosis
        • zygomycosis
      • parasitism
        • amoeba
        • paragonimiasis
        • echinococcosis
  • vasculitis
    • granulomatous vasculitis
    • lung disease in rheumatoid arthritis territory
  • emphysematous cyst
  • stinky stunts

 

Diagnostic tests

 

Imaging tests

The imaging tests that are usually performed to diagnose pulmonary abscess are:

  • chest X-ray
    • depicts a cavity with a hydraulic level:
      • usually with a thick wall
      • there may be pulmonary infiltrates surrounding the cavity
  • chest CT scan
    • can be more revealing than a simple X-ray
      • the emergence of very small cavities
      • in the identification of neoplastic lesions
      • the distinction between abscess and fever

The American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) recommend that CT scans be performed in patients with pneumonia who do not respond to antimicrobial therapy, as CT scans:

  • can distinguish pleural effusion from pulmonary thickening
  • identify intraparenchymal abscesses, lymphadenopathy and solid lesions

In a published large series of patients diagnosed with pulmonary abscess the imaging findings were:

  • unilateral lesions in 96.8% of cases
  • simultaneous presence of pleural effusion in 9.5% of cases
  • anatomical location of the abscess
    • posterior part of the upper lobe or apical part of the lower lobe in 85.3% of cases
    • basal parts of the lower lobe in 11.5%
    • in the medial lobe or glottis at 3.2%
  • diameter of the abscess
    • <4cm at a rate of 15.9%
    • 4-8cm at a rate of 66%
    • >8cm at a rate of 18.3%

Transthoracic colour ultrasound can be useful in the differential diagnosis between pulmonary abscess and fever, where the demonstration of vascularisation in the thickening surrounding the abscess cavity confirms the presence of a peripheral pulmonary abscess with:

  • 94% sensitivity
  • 100% specialty
  • 100% positive predictive value
  • 94% negative predictive value
Chest X-ray with lung abscess
CT scan with lung abscess
Transthoracic ultrasound with lung abscess

Microbiological tests

Gram staining and sputum culture of patients with pulmonary abscess due to aspiration are characterized by:

  • on Gram staining abundant neutrophils and complex microbial flora can be observed
  • often in sputum there is an overgrowth of respiratory tract flora which makes it difficult to isolate pathogens
  • for the collection of non-allocated biological material for cultivation (which is not often required) can be carried out:
    • intertracheal suctions
    • thoracocentesis
    • transbronchoscopic bronchial lavage
    • blood cultures (which are rarely positive for anaerobic infections)
  • the usefulness of bronchoscopic bronchial lavage has not been documented

Gram stain and sputum culture appear to be more effective in patients with monomicrobial infections or when the pulmonary abscess is a secondary complication:

  • anaerobic infections
  • tuberculosis
  • fungal infection
  • parasitism

Treatment

Summary of the therapeutic approach

  • first-line treatment is the administration of antibiotics
    • the antibiotics given are similar to those given for the treatment of aspiration pneumonia
    • το προτιμώμενο αντιβιοτικό σχήμα περιλαμβάνει αρχικά ενδοφλέβια χορήγηση κλινδαμυκίνης 600mg κάθε 8 ώρες (600mg X 3 iv), που ακολουθείται από του στόματος χορήγηση κλινδαμυκίνης 50-300mg κάθε 6 ώρες (50-300mg X 4 pos)
    • alternative antibiotic regimens include:
    • targeted antibiotics based on an antibiogram, if the pathogen can be isolated
    • the optimal duration of administration of the antibiotic regimen has not been determined
      • usually, most patients are treated > 6-8 weeks
      • the duration of treatment may be based on clinical and imaging response
  • in patients who fail medical treatment, surgical treatment or percutaneous or endoscopic drainage of the abscess may be required
  • no comparative studies have been conducted on early surgical treatment or invasive drainage of the abscess in patients at risk of failure of antibiotic treatment

Medication therapy

Surgical treatment

Patient monitoring

Patients are followed up with clinical examination and imaging tests for as long as necessary, as the optimal duration of the antibiotic regimen has not been determined:

  • usually, most patients are treated > 6-8 weeks
  • the duration of treatment may be based on clinical and imaging response
  • some experts recommend continuing treatment until the chest X-ray "clears" or the imaged lesion remains small and stable

Complications and prognosis

Complications

Pulmonary abscess in case of inadequate treatment can cause:

  • Inspiration
  • bronchopleural fistula
  • pneumocele
  • haemoptysis
  • respiratory distress syndrome
  • metastatic brain abscess
  • pneumothorax
  • amyloidosis

Forecast

Prevention and population control

Prevention

The effort to prevent the occurrence of pulmonary abscess consists mainly in the prevention of aspiration episodes and subsequent aspiration pneumonia.

Guidelines

Information for patients

Brief information for patients with lung abscess

Scroll to Top